趣旨説明:河村 好章(愛知学院大薬) (1:15 PM - 1:20 PM)
Session information
Symposium
[S37] Understanding new pathologies and novel treatment strategies unraveled from the microbiome
Sat. Mar 30, 2024 1:15 PM - 3:15 PM [Room 302] Conference Center 302 (3F)
Organizer: Yoshiaki Kawamura (Aichi Gakuin Uni.v Sch. Pharm.), Takashi Sugita (Meiji Pharm. Univ.)
The human body hosts a diverse microbiome comprising over 100 trillion microorganisms, increasingly acknowledged for its profound connection to health and disease. Recent findings suggest that the microbiome plays a pivotal role in regulating infection control, immune responses, and even neuropsychiatric functions. At this symposium, we are proud to convene leading experts engaged in groundbreaking research across various disciplines. They will delve into the latest insights on how disease states are influenced by the microbiome, as revealed through advanced analysis, and discuss cutting-edge research developments. Additionally, we will showcase innovative treatments utilizing host-specific phages, marking a new frontier in therapeutic strategies. This symposium aims to spur forward-thinking discussions, enhance understanding of the human microbiome's critical role in health and disease and inspire the next wave of clinical innovations."
1:20 PM - 1:35 PM
○Yoshiaki Kawamura1 (1. Aichi Gakuin Univ Sch Pharm)
1:35 PM - 1:55 PM
○Yun-Gi Kim1 (1. Fac. Pharm., Keio Univ.)
1:55 PM - 2:15 PM
Narumi Ishihara1, Shunsuke Kimura1, ○Koji Hase1,2 (1. Facul. of Pharm., Keio Univ., 2. IFeS, Facul. of Food and Agr. Sci., Fukushima Univ.)
2:15 PM - 2:35 PM
○Hideki Hida1 (1. Nagoya City Univ Grad Sch Med Sci)
2:35 PM - 2:55 PM
○Kotaro Kiga1 (1. Drug Vaccine Dev., NIID)
2:55 PM - 3:10 PM
○Takashi Sugita1 (1. Meiji Pharm Univ)
まとめ:杉田 隆(明治薬大) (3:10 PM - 3:15 PM)